Theta Research
  • Console
  • Supply Chain
  • Stock ResearchPro
  • Event Outlook
θDecision Desk
  • DBDashboard55
  • POPortfolio
  • CACalendar
  • SCScreening
  • IMImpact
  • RERegime
  • TRTrack Record

Conclusions are published after independent cross-review.

GSThe Goldman Sachs Group, Inc.
BuyConviction 2.8/10PW target $929.00-12.0%Rated Apr 29Full research page

Verdict

Goldman Sachs is executing the most successful strategic pivot in modern Wall Street history — from a volatile, capital-markets-dependent trading house to a diversified financial platform anchored by $3.6T in assets under supervision and the world's largest alternatives franchise ($540B+ AUM). The Q1 2026 beat ($17.55 EPS, record equities revenue of $5.33B) validates that this is not a cyclical upswing but a structural transformation: 70% of the efficiency ratio improvement is from durable fee-based revenue growth in AWM and alternatives, not just trading upside. At ~13x forward earnings with 19.8% annualized ROE, the stock prices GS as a cyclical bank — not a platform that returned $16.8B to shareholders in 2025 while growing book value per share 12% YoY.

ScenarioProb.TargetDriver
Bull25%$1,168.00M&A and IPO cycle accelerates through 2027 — IB fee pool grows 15%+ as deal backlog clears
Base50%$949.00M&A cycle normalizes — IB fees grow 5-10% annually driven by backlog and sponsor activity
Bear25%$650.00Capital markets freeze — M&A/IPO activity drops 20%+ due to recession or policy shock

Change history

  • Jun 9View held

    Anthropic IPO lead-underwriter mandate (June 3, 2026) + price re-rating above base target

  • Apr 29View held

    Deep research initiation post-Q1 2026 earnings

Watching

  • Q1 2026 earnings release — COMPLETED: record equities $5.33B, $17.55 EPS, 19.8% ROEApr 1385d ago
  • CCAR / stress test results (Federal Reserve annual)Jun 307d ago
  • Q2 2026 earnings release and conference callJul 14in 7d
  • Q2 2026 earnings — sustainability test: can equities/trading sustain Q1 levels or was it volatility-driven?Jul 14in 7d
  • Alternatives AUM path to $600B — continued $100B+ annual fundraising validates platform thesisJul 14in 7d
M&A/IPO cycle acceleration — sponsor deal backlog clearing, secondary market volumes +60% YoY
Jul 14
in 7d
  • 2026 Investor Day (if announced — potential platform transformation update)Sep 30in 85d
  • Anthropic IPO lead-underwriter mandate — pricing and ECM fee recognition; marquee AI-IPO confirming ECM pipeline reopeningOct 1in 86d
  • Q3 2026 earnings release and conference callOct 13in 98d
  • AWM fee revenue mix crossing 35% threshold — milestone toward platform re-ratingOct 13in 98d
  • Basel III endgame final rule announcementDec 31in 177d
  • Basel III endgame finalization — potential ~25% capital requirement increase constraining capital returnDec 31in 177d
  • Q4 2026 / FY2026 earnings release and conference callJan 19, 2027in 196d
  • M&A deal announcements decline 20%+ YoY for 2 consecutive quarters — IB fee pool contraction
  • VIX sustains below 12 for 3+ months — normalizing volatility compresses trading revenue from Q1 2026 record levels
  • Basel III endgame finalized with 20%+ capital requirement increase — constrains capital return and ROE
  • Q2 2026 equities trading revenue falls below $4B — Q1 record was tariff-volatility anomaly, not structural
  • Alternatives fundraising pace slows to below $70B annually — LP allocation fatigue or performance disappointment
  • ROE falls below 13% for 2 consecutive quarters — market re-rates GS as cyclical bank
  • Credit losses in private credit portfolio or Platform Solutions rundown exceed $500M in a single quarter
  • Alternatives AUM crosses $600B — validates platform transformation and durable fee revenue growth
  • AWM fee revenue exceeds 50% of total net revenues on a trailing 4-quarter basis — triggers re-rating to MS-level multiple
  • ROE sustains above 17% for 3+ quarters — market begins pricing GS as platform, not cyclical bank
  • M&A/IPO pipeline accelerates 15%+ YoY through 2027 — deal backlog clearing drives IB fee pool expansion
  • Capital return increases to $20B+ annually as CET1 ratio allows higher distributions
  • Anthropic IPO (~$965B valuation, Oct 2026 target) prices with GS as lead underwriter and ECM fees recognize — validates AI-IPO pipeline reopening and IB/ECM cycle acceleration
  • Latest notes

    • Jun 9Update — GS lands Anthropic IPO lead mandate; stock above base target
    • Apr 29Deep Research: GS — Platform Transformation Thesis
    • Apr 29Competitive Deep Dive — 2026-04-29

    Exposure

    1-hop
    Suppliers

    None mapped.

    Customers
    • MET

    Options radar

    Concept — illustrative data
    • Jun 30Call$110.00Aug 211,200 ct$540K
    • Jun 30Call$105.00Jul 17800 ct$216K
    • Jun 29Put$95.00Aug 21600 ct$168K
    Unusual volume3.2x 20-day avg call volume
    IV shift30-day IV 41% → 48%

    Positioning skews toward near-term upside